Literature DB >> 29808158

Attitude and Vaccination Status of Healthcare Workers against Hepatitis B Infection in a Teaching Hospital, Ethiopia.

Mohammed Akibu1, Sodere Nurgi1, Mesfin Tadese1, Wendwesen Dibekulu Tsega2.   

Abstract

BACKGROUND: World Health Organization and Centers for Disease Control and Prevention recommend all health professionals to get vaccinated against hepatitis B virus before they start the clinical attachments during their stay in the medical school. However, only 18-39% of healthcare workers in low- and middle-income countries received the vaccine. Therefore, this study aims to determine the attitude and vaccination status of health professionals working at Adama General Hospital and Medical College.
METHODS: An institution-based cross-sectional study was conducted from December 2016 to February 2017 with 403 health professionals working at Adama General Hospital and Medical College. Data were collected using self-administered questionnaire distributed at the participant's work unit and analyzed using SPSS version 20. Multiple logistic regression analysis was conducted to identify factors that affect the complete vaccination status and p value < 0.05 was considered statistically significant. RESULT: The prevalence of complete vaccination against hepatitis B virus was 25.6%. The most frequently mentioned reasons for not being vaccinated were high cost of the vaccine (41%) and unavailability of the vaccine (36%). More than three-fourths (77.8%) of study participants strongly agreed that hepatitis B is a major public health threat and there was tendency among participants to believe that their profession will put them at increased risk of acquiring the disease (strongly agreed: 75.9%). Attending infection-prevention training [AOR = 2.3; 95% CI, 1.24-6.31], history of exposure to risky behavior [AOR = 5.5; 95% CI, 2.86-9.29], and long years of work experience [AOR = 3.1; 95% CI, 1.98-5.24] were statistically significant with complete vaccination status.
CONCLUSION: Only one-quarter of health professionals received the recommended full dose of the vaccine. Sustained hepatitis B vaccination programs for healthcare workers need to be established by collaboration of different stakeholders to optimize health professionals' safety against this contagious infection.

Entities:  

Year:  2018        PMID: 29808158      PMCID: PMC5901831          DOI: 10.1155/2018/6705305

Source DB:  PubMed          Journal:  Scientifica (Cairo)        ISSN: 2090-908X


1. Introduction

Hepatitis B infection has been a major public health threat that affects nearly two billion people worldwide with 350 million chronic cases and more than 2 million deaths every year [1]. The disease is mainly transmitted by percutaneous or mucosal exposure to infected blood or other bodily fluids and numerous forms of human contact have been suggested to transmit hepatitis B virus (HBV): perinatal/mother-to-child, nonsexual, sexual, needle-sharing, and occupational/healthcare-related forms [2]. The disease causes chronic infection, resulting in cirrhosis of the liver, liver cancer, liver failure, and death. Furthermore, extrahepatic lesions can occur in other organs of the body, particularly in the kidney [3]. Since contact with body fluid of an infected person is one of the principal modes of transmission of the causative virus of hepatitis B infection, healthcare workers (HCWs) constitute one of the high-risk groups for this infection because of their repeated exposure [4]. World Health Organization (WHO) estimated that, of the 35 million HCWs worldwide, 3 million experience percutaneous exposure to blood pathogens each year and 2 million of those HCWs are exposed to hepatitis B virus [5-8]. In general, prevalence of HBV infection among healthcare providers is approximately ten times greater than the general population [9]. More importantly, HCWs in developing countries are at serious risk of infection from blood-borne pathogens because of the high prevalence of such pathogens in many poorer regions of the world, especially in endemic areas like Sub-Saharan Africa [10]. Due to the absence of medical treatment that can cure hepatitis B virus (HBV) infection, hepatitis B vaccine is the single most effective and safe strategy for the prevention of the disease if appropriate doses are given during a period of 6 months. The vaccine provides more than 90% effective protection after all doses [11, 12]. As part of occupational safety measures, WHO, Centers for Disease Control and Prevention (CDC), and the Ethiopian Federal Ministry of Health (FMOH) infection-prevention guidelines recommend that all health professionals should be vaccinated against HBV before they started the clinical attachments during their stay in the medical school [13-15]. However, in spite of higher vulnerability among health professionals, the WHO estimate showed that HBV vaccination coverage among HCWs is only 18–39% in low- and middle-income countries compared to 67–79% in developed countries [13]. In Ethiopia, hepatitis B infection cases account for 12% of the hospital admissions and 31% of the mortality in medical wards of Ethiopian hospitals [16]. Specifically, studies conducted on health professionals revealed 9.7% prevalence of hepatitis B surface antigen (HBsAg) [17]. On top of that, some studies also reported lower coverage of hepatitis B vaccination among health professionals [18-21]. Therefore, this study aimed to assess the attitude and vaccination status of health professionals against hepatitis B virus infection and factors associated with complete immunization.

2. Methods

2.1. Study Design and Setting

The study was conducted at Adama General Hospital and Medical College, Adama, Ethiopia. The city is located 99 km away from Addis Ababa, the capital city of Ethiopia, to the southeast. This teaching hospital has catchment population of about 5 millions, serving as referral hospital for all nearby hospitals and adjacent regions. It has more than 500 healthcare workers providing the service in different units. This is an institution-based cross-sectional study conducted from December 2016 to February 2017.

2.2. Study Participants

All health professionals working at Adama General Hospital and Medical College were included into the study irrespective of their working unit and duration of stay to minimize the risk of selection bias.

2.3. Variables and Measurement

Complete immunization against hepatitis B virus and attitude of healthcare workers towards hepatitis B infection and its vaccination were the outcome variables measured in the study, whereas various sociodemographic variables (age, profession, working unit, and years of work experience) and occupational variables (training on infection-prevention and history of exposure to risky behavior) were the independent variables. Complete immunization was measured using the following question: “how many doses of the vaccine have you taken?” Taking three or more doses of the vaccine was defined as complete immunization. Attitude was measured on the cumulative score of thirteen questions designed to assess healthcare workers' attitude towards hepatitis B infection and its vaccination. Each attitude question contains ordinal categorical response rated in 5-point Likert scale [i.e., 1 = strongly disagree; 5 = strongly agree] and these questions were adapted from previous literatures [19, 22, 23]. Overall, the scores for each participant were summed and study participants who have responded to ≥60% of attitude questions positively were regarded as having favorable attitude.

2.4. Sample Size and Sampling Procedure

Single population proportion formula was used to calculate the sample size given the prevalence of hepatitis B vaccination for healthcare workers of 50% to obtain a relatively larger sample size, confidence level of 95%, and marginal error of 5%. The final sample size was 403 after adjustment for 5% nonrespondent rate. The total sample size was proportionally allocated to each of the working departments in the hospital. The list of health professionals working in each department was obtained from the hospital and simple random sampling technique was employed to select the study subjects from the list.

2.5. Data Collection and Quality Control

Data were collected using self-administered questionnaire distributed at the participant's work unit. Data collection was performed by three nursing professionals through distributing and recollecting the questionnaire prepared in English. Pretesting was performed on 5% of the total sample size in other health facilities and a necessary adjustment was made prior to the actual data collection. The questionnaire was also tested for internal consistency (reliability) by Cronbach's Alpha test using Statistical Package for Social Sciences (SPSS) version 20.0. Similarly, content validity was cross-checked by a public health expert. The completeness, consistency, and accuracy of the collected data were examined by principal investigator every day.

2.6. Data Processing and Analysis

The data were coded, cleaned, and entered into Epi Info version 7 and it was exported to SPSS version 20 for statistical analysis. First, descriptive statistics were generated followed by binary and multiple logistic regressions to examine the possible association between the determinant and the outcome variable. In this model, P value < 0.05 was used to declare the presence of statistically significant association. The result was reported strictly following STrengthening the Reporting of OBservational Studies in Epidemiology (STROBE) statement (supplementary file (available here)).

3. Result

3.1. Sociodemographic Characteristics of the Study Participants

A total of 386 participants completed the questionnaire, making a response rate of 97%. More than half (198 (51.2%)) of participants were male and the age of study participants ranged from 21 to 64 with the mean age of 28.45 (±3.2) years. The professional background of respondents was dominated by nurses (203 (52.7%)) followed by medical doctors (52 (13.5%)) (Table 1).
Table 1

Socio-demographic characteristics of health professionals, AHMC, Ethiopia 2017.

VariableFrequency (n = 386)Percent (%)
Sex
 Male19851.2
 Female18848.8
Age (years)
 20–303316.3
 31–409446.3
 >4073.4
Marital status
 Unmarried21054.4
 Married17645.6
Religion
 Orthodox26669
 Protestant7218.7
 Muslim358.9
 Othera133.4
Profession
 Nurse20352.7
 Midwife4411.3
 Lab technician256.4
 General Practitioner5213.5
 Dental Doctor143.6
 Pharmacist205.2
 Specialist287.3
Working department
 Inpatient department9223.8
 Outpatient11429.5
 Emergency department369.3
 Delivery unit5313.8
 Laboratory287.3
 OR department328.3
 Dental department318
Work experience
 <5 years22758.7
 ≥5 years15941.3
Training on infection prevention
 Yes22458
 No16242

 acatholic, woke feta, Adventist.

3.2. Attitude towards Hepatitis B Infection and Its Vaccination

More than three-fourths (77.8%) of study participants strongly agreed that hepatitis B is a major public health threat. Similarly, more than half (51.2%) of healthcare workers strongly agreed that hepatitis B vaccine should be obligatory to take. There was tendency among participants to believe that their profession will put them at increased risk of acquiring the disease (strongly agreed: 75.9%). Participants also stated that following the infection-prevention guideline has a potential benefit on reducing the chance of contracting hepatitis B infection (strongly agreed and agreed: 85.2%) (Table 2).
Table 2

Attitude of health professional towards hepatitis B infection and its vaccination, AHMC, Ethiopia, in 2017.

ItemsStrongly agreeAgreeNeutralDisagreeStrongly Disagree
HBV is serious public health problem300 (77.8%)70 (18.2%)4 (1.0%)10 (2.5%)2 (0.5%)
All patients should be tested for HBV before they receive healthcare80 (20.7%)116 (30.1%)99 (25.6%)68 (17.7%)23 (5.9%)
Being a health professional puts you at greatest risk of HBV infection292 (75.9%)80 (20.6%)8 (2%)4 (1%)2 (0.5%)
Following infection control guidelines will protect me from being infected with HBV and HCV at work203 (52.7%)125 (32.5%)21 (5.4%)29 (7.4%)8 (2,0%)
I deliver the same standard of care to patients with HBV as I do for other patients46 (11.8%)148 (38.4%)32 (8.4%)101 (26.1%)59 (15.3%)
It is appropriate not to spend much time when caring HBV-infected patients91 (23.6%)109 (28.2%)46 (11.8%)72 (18.7%)68 (17.7%)
A healthcare worker can infect patients with HBV112 (29.1%)141 (36.5%)15 (3.9%)78 (20.2%)40 (10.3%)
Health professionals who are hepatitis B virus-positive should not give healthcare services to patients25 (6.4%)32 (8.4%)63 (16.3%)118 (30.5%)148 (38.4%)
I do not trust HBV vaccine17 (4.3%)45 (11.7%)54 (14%)109 (28.3%)161 (41.7%)
HBV vaccine should be compulsory198 (51.2%)91 (23.7%)25 (6.4%)64 (16.7%)8 (2%)
HB vaccine is safe but is expensive236 (61.1%)89 (23.2%)36 (9.4%)13 (3.4%)12 (3.0%)
After exposure to contagious flu-id/ material, the vaccinereduces likelihood of being HBV-positive122 (31.5%)97 (25.1%)49 (12.8%)80 (20.7%)38 (9.9%)

3.3. History of Occupational Exposure and Perceived Risk of Disease Acquisition

Healthcare workers were asked to rate their perceived risk of acquiring the infection. The respondents reported that they have very high (51 (13.3%)), high (80 (20.7%)), medium (101 (26.1%)), low (142 (36.9%)), and very low (12 (3%)) risk of contracting the disease. Nearly half (182 (47.3%)) of healthcare workers had history of occupational exposure to risky conditions. Unprotected mucocutaneous fluid contact on intact skin (121 (66.7%)), sharp-needle injury (72 (39.6%)), and body fluid splash through body openings (51 (28.1%)) represent the three main forms of exposure. The most common (130 (71.3%)) action taken after the exposure was washing the area of exposure with soap, water, or antiseptic (Table 3).
Table 3

Exposure to occupational risk of hepatitis B among health professionals, AHMC, Ethiopia, in 2017.

VariableFrequencyPercentage
Occupational exposure
 Yes18247.3
 No20452.8
Exposure to sharp injury
 Yes7239.6
 No11060.4
Unprotected mucocutaneous fluid contact on intact skin
 Yes12166.7
 No6133.3
Body fluid contact through body openings
 Yes5128.1
 No13171.9
Measure taken after exposure
 Testing the patient right away7139
 Washing with soap, water, or antiseptic13071.3
 Immediate report8044.2
 Allowing the injury area to bleed2514
 Wait and test myself116.2

3.4. Vaccination and Postvaccination Testing

Only three in ten (118 (30.4%)) participants had been screened for hepatitis B surface antigen. Regarding the vaccination status of study participants, more than half (223 (57.7%)) of them reported history vaccination at least once. However, less than half (99 (44.5%)) of these participants received the recommended three doses of the vaccine, of which 36 (36.8) tested after the vaccine to check for the vaccine effect and all of them were protected (anti-HB titer > 10 MIU/ml). Among healthcare workers who did not take the vaccine, vaccine unavailability through government channels (36%), high cost of the vaccine for private access (41%), and not giving much concern about this issue (26%) represent the major reasons stated for not being vaccinated (Table 4).
Table 4

Vaccination status and reason for not taking the vaccine among health professionals, AHMC, Ethiopia, in 2017.

VariablesFrequency NPercentage (%)
Ever screened for hepatitis B
 Screened11830.4
 Not screened26869.6
Vaccination for hepatitis B
 Vaccinated22357.7
 Not vaccinated16342.3
Vaccination dose
 Once only (incomplete vaccination)7533.6
 Received two doses (incomplete vaccination)4921.9
 Three complete doses (fully vaccinated)9944.5
Complete vaccination status
 Fully vaccinated9944.5
 Incomplete vaccination12455.4
Have you been tested after full dose?
 Tested for the vaccine effect3636.4
 Not tested6363.8
Test result
 Protected (anti-HB titer > 10 MIU/ml)36100
Reason for incomplete vaccination
 Being busy4737.9
 I feel I am protected1512.2
 Forget it at all2822.6
 Waiting for the next dose3427.3
Reason for not taking the vaccine
 The vaccine was not available through government channels5936
 The vaccine is very expensive for private access6741
 I did not give it too much emphasis4226
 The side effect would be worse138
 The duration of total dose is too long2515.4
 Othersb63.7

 bI do not think I am at risk, I never thought about it, or I have no reason.

3.5. Factors Associated with Vaccination Status

Multivariate analysis of factors affecting the practice of full dose vaccination revealed that previous exposure to occupational risks of hepatitis B infection, years of work experience and infection-prevention training were statistically significant with complete vaccination status. Participants whose years of work experience were ≥5 years had 3 times (AOR = 3.1 (.98–5.24)) greater chance of receiving the vaccine. Likewise, previous history of exposure to occupational risks of hepatitis B infection resulted in 5.5 times (AOR = 5.5 (2.86–9.29)) increased practice of receiving full dose vaccine. Similarly, participants who attended infection-prevention training were 2.3 times (AOR = 2.3 (1.24–6.31)) more likely to take the recommended vaccine dose than their counterparts (Table 5).
Table 5

Logistic regression of factors affecting full vaccination status among HCWs who received at least one dose, AMHC, Ethiopia, in 2017.

Variable Fully vaccinatedCOR (95% CI)AOR (95% CI)
YesNo
Sex
 Male374911
 Female62753.45 (1.82–6.7)1.06 (0.84–3.62)
Work experience
<5 years287411
 ≥5 years71504.8 (2.64–7.44)3.1 (1.98–5.24 )
Profession
 Nurse35450.87 (0.67–2.13)0.22 (0.03–1.45)
 Midwife14171.5 (0.68–2.75)0.6 (0.07–4.64)
 Lab technician12132.6 (1.36–5.71)1.72 (0.89–2.42)
 General practitioner16192.1 (0.92–6.37)0.03 (0.04–2.21)
 Pharmacist581.65 (0.401–4.62)0.82 (0.27–3.91)
 Dental doctor691.39 (0.44–3.64)1.57 (0.38–6.19)
 Specialist111311
Training on IP
 Yes67483.4 (2.77–8.92)2.3 (1.24–6.31)
 No327611
Work unit
 Inpatient unit12252.93 (2.91–7.68)1.07 (0.94–3.75)
 Dental department4110.063 (0.0057–0.84)0.071 (0.003–1.83)
 Emergency unit13161.4 (0.63–3.18)1.6 (0.71–4.2)
 Delivery unit23214.64 (1.43–19.7)2.48 (0.82–7.29)
 Laboratory2175.45 (1.74–9.27)2.16 (0.018–6.23)
 OR department6131.39 (0.34–3.24)1.56 (0.40–6.24)
 Outpatient unit203111
Exposure history
 Yes73386.4 (3.43–11.58)5.5 (2.86–9.29)
 No268611

∗ indicates statistically significant value.

4. Discussion

Hepatitis B vaccination is one of the most important primary prevention ways of this contagious disease and immunization against this infectious agent provides an optimal protection for individuals at risk [24]. World Health Organization estimated that hepatitis B vaccine's coverage among healthcare providers is 18% in Africa, which represents the least figure [25]. Therefore, this study assessed the coverage of hepatitis B vaccine among healthcare workers of Adama General Hospital and Medical College, Ethiopia. In this study, it appeared that the proportion of healthcare workers who received hepatitis B vaccine at least once was 57.7%. This finding is in the range of 47%–60% reported in different studies of different areas [20, 26–28]. However, the result is relatively lower compared to the findings reported from Iraq (65.7%), Kuwait (74.4%), India (78%), and Nigeria (91.9%) [29-32]. The complete reason for low vaccine coverage of our survey compared to these studies cannot be completely discernible. However, difference in vaccine accessibility across countries, relatively late addition of hepatitis B vaccine into national immunization program, and certain variability between the sociodemographic characteristics of the study participants might explain this discrepancy. The proportion of healthcare workers who completed the recommended three or more doses of the vaccine constitutes 25.6% of the whole study participants. This figure is lower compared to reports of other studies conducted in Pakistan (57.6%), Malaysia (58.6%), and Libya (72%) [33-35]. This lower rate of complete immunization reflects the need for well effective strategy that enhances increased rate of compliance with recommended vaccine doses. Furthermore, health professionals have to be supported and inspired to check their protection status to make sure whether or not they require additional doses of the vaccine to get protected. Regarding the attitude of healthcare workers towards hepatitis B infection and its vaccination, the majority of them showed encouraging positive attitude towards the issue. The majority (77.8%) of healthcare workers strongly agreed that hepatitis B is a major public health threat and almost all (96.5%) of them stated that their job puts them at risk of acquiring the disease. Regarding the importance of vaccination, around 75% of healthcare workers agreed that hepatitis B vaccination should be compulsory. These statements are also similarly reported at comparable rate in other studies conducted in Kuwait and Gondar University Hospital [30, 36]. Among healthcare workers who did not receive the vaccine, the most frequently mentioned reason was high cost of the vaccine for private access. Similarly, studies from different areas reported the same finding [20, 22, 37, 38]. Another barrier mentioned was vaccine unavailability, which was reported by 36% of participants. Likewise, this report is in line with the reasons mentioned for vaccine refusal in different articles [19, 28, 39]. This is an input for stakeholders to establish an effective program that focuses on vaccine availability at affordable cost to meet the demand of healthcare workers. According to our study, nearly half (47.3%) of healthcare workers have been exposed to risky situation for hepatitis B infection. Of these, 39.6% reported exposure to sharp-needle injury. A study conducted in Pakistan reported that the percentage of healthcare workers who had experienced at least one sharp injury in a year was 44% and another study conducted in Gondar University Hospital also revealed that 49.2% of healthcare workers had been exposed to occupational risks [36, 40]. This evidence emphasizes the importance of hepatitis B vaccination for this group of people in particular given the extent of their exposure. This study revealed that healthcare workers who have been exposed to risky conditions of hepatitis B virus had increased chance of receiving complete immunization. This finding is in line with reports from north India, Zambia, and northwest Pakistan [23, 28, 41]. This might be because of increased perceived threat of getting such blood-borne disease after exposure to risky conditions. Years of work experience were another important factor that influenced the complete vaccination status of healthcare workers. Similarly, other studies showed that there was an increased chance to get full vaccination with increasing number of years of work experience [21, 42, 43]. This might be because of the fact that healthcare workers who joined the institutions later might not have benefited from vaccination because of sporadic availability of the vaccine through government channels. Likewise, increased length of work years would result in higher rate of exposure to various risky behaviors, which in turn leads to increased perceived threat of acquiring the disease. Participants who attended infection-prevention training showed increased rate of complete immunization. Studies from Zambia and Nigeria revealed the same finding [23]. This result shows that provision of basic infection-prevention training for all hospital might have a benefit in terms of lifting up the perceived benefit of such preventive strategies among healthcare workers.

5. Limitations

Despite extensive efforts that have been made to minimize possible shortcoming of this study, the finding of this survey will be interpreted in the presence of the following inevitable limitations. The cross-sectional nature of the study does not confirm the definitive cause-and-effect relationship. There is also a possibility of admitting recall bias because of the self-reported vaccination status.

6. Conclusion

Only a small proportion of healthcare workers have taken the recommended three doses of the vaccine at Adama General Hospital and Medical College. Attending infection-prevention training, work experience, and history of exposure to risky condition were the factors that are statistically significant with the completion of the recommended three doses. High cost of the vaccine for private access and vaccine unavailability were the major barriers identified for hepatitis B vaccination. Sustained HBV vaccination programs for HCWs need to be established by collaboration of different stakeholders. Moreover, the Regional Health Bureau should offer the vaccine to HCWs free of charge by coordinating efforts from other concerned bodies. Similarly, the government should design a national strategy that focuses on vaccinating medical and health science students before they are assigned to their work place.
  25 in total

Review 1.  The value of vaccination: a global perspective.

Authors:  Jenifer Ehreth
Journal:  Vaccine       Date:  2003-10-01       Impact factor: 3.641

2.  Global epidemiology of hepatitis B virus infection: new estimates of age-specific HBsAg seroprevalence and endemicity.

Authors:  J J Ott; G A Stevens; J Groeger; S T Wiersma
Journal:  Vaccine       Date:  2012-01-24       Impact factor: 3.641

Review 3.  Hepatitis B virus infection: epidemiology and vaccination.

Authors:  Colin W Shepard; Edgar P Simard; Lyn Finelli; Anthony E Fiore; Beth P Bell
Journal:  Epidemiol Rev       Date:  2006-06-05       Impact factor: 6.222

4.  [Hepatitis B vaccination status and associated factors among health care workers in Burkina Faso].

Authors:  H G Ouédraogo; S Kouanda; S Tiendrébeogo; G A Konseimbo; C E Yetta; E Tiendrébeogo; A A Savadogo; B Sondo
Journal:  Med Sante Trop       Date:  2013 Jan-Mar

5.  Estimation of the global burden of disease attributable to contaminated sharps injuries among health-care workers.

Authors:  Annette Prüss-Ustün; Elisabetta Rapiti; Yvan Hutin
Journal:  Am J Ind Med       Date:  2005-12       Impact factor: 2.214

6.  Hepatitis B vaccination status among healthcare workers in a tertiary care hospital in Tripoli, Libya.

Authors:  Hisham Ziglam; Mabrouk El-Hattab; Noura Shingheer; Abdulaziz Zorgani; Omar Elahmer
Journal:  J Infect Public Health       Date:  2013-04-25       Impact factor: 3.718

7.  Hepatitis B vaccination status among health workers in Enugu, Nigeria.

Authors:  R C Ibekwe; N Ibeziako
Journal:  Niger J Clin Pract       Date:  2006-06       Impact factor: 0.968

Review 8.  Epidemiology, prevention and treatment of viral hepatitis with emphasis on new developments.

Authors:  E Tsega
Journal:  Ethiop Med J       Date:  2000-04

Review 9.  Infection control: its evolution to the current standard precautions.

Authors:  John A Molinari
Journal:  J Am Dent Assoc       Date:  2003-05       Impact factor: 3.634

10.  Hepatitis B vaccination among primary health care workers in Northwest Pakistan.

Authors:  Mohammad Tahir Yousafzai; Rubina Qasim; Rehana Khalil; Mohammad Fazil Kakakhel; Shafiq Ur Rehman
Journal:  Int J Health Sci (Qassim)       Date:  2014-01
View more
  15 in total

1.  Intention to Receive the Second Round of COVID-19 Vaccine Among Healthcare Workers in Eastern Ethiopia.

Authors:  Bewunetu Zewude; Abreham Belachew
Journal:  Infect Drug Resist       Date:  2021-08-11       Impact factor: 4.003

2.  A positive attitude among primary healthcare providers predicts better hepatitis B prevention practices: evidence from a cross-sectional survey in Wakiso district, Central Uganda.

Authors:  Tonny Ssekamatte; John Bosco Isunju; Paul Alex Kimoga Zirimala; Samuel Etajak; Saul Kamukama; Mathias Seviiri; Mary Nakafeero; Aisha Nalugya; Solomon Tsebeni Wafula; Edwinah Atusingwize; Justine N Bukenya; Richard K Mugambe
Journal:  Health Psychol Behav Med       Date:  2021-04-07

3.  An updated systematic review and meta-analysis of the prevalence of hepatitis B virus in Ethiopia.

Authors:  Teshiwal Deress Yazie; Mekonnen Girma Tebeje
Journal:  BMC Infect Dis       Date:  2019-10-29       Impact factor: 3.090

4.  A Survey on Medical, Dental, and Pharmacy Students' Knowledge, Attitude, and Practice about Hepatitis B Infection in a Private Medical University of Malaysia.

Authors:  Dinesh Kumar Upadhyay; Yuvati Manirajan; Muhammad Zahid Iqbal; Neeraj Paliwal; Sonam Pandey
Journal:  J Res Pharm Pract       Date:  2020-10-08

5.  Assessing Level of Knowledge and Uptake of Hepatitis B Vaccination among Health Care Workers at Juba Teaching Hospital, Juba City, South Sudan.

Authors:  John Bosco Alege; Godfrey Gulom; Alphonse Ochom; Viola Emmanuel Kaku
Journal:  Adv Prev Med       Date:  2020-12-24

6.  Hepatitis B virus infection and its associated factors among medical waste collectors at public health facilities in eastern Ethiopia: a facility-based cross-sectional study.

Authors:  Degu Abate Mengiste; Abebe Tolera Dirbsa; Behailu Hawulte Ayele; Tewodros Tesfa Hailegiyorgis
Journal:  BMC Infect Dis       Date:  2021-02-27       Impact factor: 3.090

7.  Willingness to Take COVID-19 Vaccine Among People Most at Risk of Exposure in Southern Ethiopia.

Authors:  Bewunetu Zewude; Tewodros Habtegiorgis
Journal:  Pragmat Obs Res       Date:  2021-05-27

Review 8.  Knowledge, Vaccination Status, and Reasons for Avoiding Vaccinations against Hepatitis B in Developing Countries: A Systematic Review.

Authors:  Putri Bungsu Machmud; Saskia Glasauer; Cornelia Gottschick; Rafael Mikolajczyk
Journal:  Vaccines (Basel)       Date:  2021-06-09

9.  Hepatitis B Awareness and Vaccination Patterns among Healthcare Workers in Africa.

Authors:  Shemal M Shah; Holly Rodin; Hope Pogemiller; Oluwadayo Magbagbeola; Kenneth Ssebambulidde; Anteneh Zewde; Matthew Goers; Benjamin Katz; Itegbemie Obaitan; Ehab Fawzy Abdo; Sahar Mohamed Hassany; Mohamed Elbadry; Abdelmajeed Mahmoud Moussa; Jasintha Mtengezo; Mark Dedzoe; Benjamin Henkle; Martha Binta Bah; Matthew Sabongi; Johnstone Kayandabila; Robert Fell; Ifeorah Ijeoma; Lucy Ochola; Mirghani Yousif; Jose D Debes
Journal:  Am J Trop Med Hyg       Date:  2020-10-01       Impact factor: 3.707

10.  Full-dose hepatitis B virus vaccination coverage and associated factors among health care workers in Ethiopia: A systematic review and meta-analysis.

Authors:  Nefsu Awoke; Henok Mulgeta; Tsegaye Lolaso; Tiwabwork Tekalign; Serawit Samuel; Mohammed Suleiman Obsa; Robera Olana
Journal:  PLoS One       Date:  2020-10-27       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.